Works by Hartung, H. P.

Results: 114

Assessing the Intensity and Frequency of Symptoms of Mental Disorders in Patients with Neurological Disorders.

Published in:

European Psychiatry, 2015, v. 30, p. 415, doi. 10.1016/S0924-9338(15)30330-8

By:

Ruttmann, A.;
Schmidt-Kraepelin, C.;
Zielasek, J.;
Menge, T.;
Seitz, R.;
FRCP, H.-P. Hartung;
Gaebel, W.

Publication type:

Article

Monomethylfumarate reduces in vitro migration of mononuclear cells.

Published in:

Neurological Sciences, 2014, v. 35, n. 7, p. 1121, doi. 10.1007/s10072-014-1663-2

By:

Dehmel, T.;
Döbert, M.;
Pankratz, S.;
Leussink, V.;
Hartung, H.-P.;
Wiendl, H.;
Kieseier, B.

Publication type:

Article

Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats.

Published in:

Clinical & Experimental Immunology, 1995, v. 100, n. 2, p. 344

By:

Huitinga, I.;
Ruuls, S. R.;
Jung, S.;
van Rooijen, N.;
Hartung, H.-P.;
Dijkstra, C. D.

Publication type:

Article

Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.

Published in:

Clinical & Experimental Immunology, 1994, v. 98, n. 3, p. 494

By:

Jung, S.;
Toyka, K. V.;
Hartung, H.-P.

Publication type:

Article

Therapeutic effect of transforming growth factor-β<sub>2</sub> on actively induced EAN but not adoptive transfer EAN.

Published in:

Immunology, 1994, v. 83, n. 4, p. 545

By:

Jung, S.;
Schluesener, H. J.;
Schmidt, B.;
Fontana, A.;
Toyka, K. V.;
Hartung, H.-P.

Publication type:

Article

The Pentapeptide QYNAD Does Not Inhibit Neuronal Network Activity.

Published in:

Canadian Journal of Neurological Sciences, 2005, v. 32, n. 3, p. 344, doi. 10.1017/S0317167100004248

By:

Otto, F.;
Kieseier, B. C.;
Görtz, P.;
Hartung, H.-P.;
Siebler, M.

Publication type:

Article

Late age onset of amyotrophic lateral sclerosis is often not considered in elderly people.

Published in:

Acta Neurologica Scandinavica, 2018, v. 137, n. 3, p. 329, doi. 10.1111/ane.12869

By:

Broussalis, E.;
Grinzinger, S.;
Kunz, A. B.;
Killer‐Oberpfalzer, M.;
Haschke‐Becher, E.;
Hartung, H.‐P.;
Kraus, J.

Publication type:

Article

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Published in:

2022

By:

Willison, A. G.;
Ruck, T.;
Lenz, G.;
Hartung, H. P.;
Meuth, S. G.

Publication type:

Correction Notice

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Published in:

2022

By:

Willison, A. G.;
Ruck, T.;
Lenz, G.;
Hartung, H. P.;
Meuth, S. G.

Publication type:

Literature Review

Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis.

Published in:

2021

By:

Schweitzer, F.;
Laurent, S.;
Fink, G. R.;
Barnett, Michael H.;
Hartung, H. P.;
Warnke, C.

Publication type:

Literature Review

Alexithymia and impaired facial affect recognition in multiple sclerosis.

Published in:

Journal of Neurology, 2011, v. 258, n. 9, p. 1683, doi. 10.1007/s00415-011-6002-4

By:

Prochnow, D.;
Donell, J.;
Schäfer, R.;
Jörgens, S.;
Hartung, H. P.;
Franz, M.;
Seitz, R. J.

Publication type:

Article

Free caspase activity in CSF of patients with dementia.

Published in:

2009

By:

Albrecht, P.;
Schmitz, M.;
Otto, M.;
Hemmer, B.;
Zerr, I.;
Hartung, H.-P.;
Methner, Axel

Publication type:

Letter

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations.

Published in:

Journal of Neurology, 2008, v. 255, n. 10, p. 1449, doi. 10.1007/s00415-008-0061-1

By:

Wiendl, H.;
Toyka, K.;
Rieckmann, P.;
Gold, R.;
Hartung, H.-P.;
Hohlfeld, R.

Publication type:

Article

Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab.

Published in:

Journal of Neurology, 2008, v. 255, n. 9, p. 1436, doi. 10.1007/s00415-008-0956-x

By:

Leussink, V.;
Lehmann, H.;
Meyer zu Hörste, G.;
Hartung, H.-P.;
Stüve, O.;
Kieseier, B.

Publication type:

Article

Neutralising antibodies to interferon β in multiple sclerosis.

Published in:

Journal of Neurology, 2007, v. 254, n. 7, p. 827, doi. 10.1007/s00415-006-0486-3

By:

Hartung, H.-P.;
Polman, C.;
Bertolotto, A.;
Deisenhammer, F.;
Giovannoni, G.;
Havrdova, E.;
Hemmer, B.;
Hillert, J.;
Kappos, L.;
Kieseier, B.;
Killestein, J.;
Malcus, C.;
Comabella, M.;
Pachner, A.;
Schellekens, H.;
Sellebjerg, F.;
Selmaj, K.;
Sorensen, P.

Publication type:

Article

Treatment of active secondary progressive multiple sclerosis with treosulfan.

Published in:

Journal of Neurology, 2007, v. 254, n. 7, p. 884, doi. 10.1007/s00415-006-0459-6

By:

Wiendl, H.;
Kieseier, B.;
Weissert, R.;
Mylius, H.;
Pichlmeier, U.;
Hartung, H.-P.;
Melms, A.;
Kuker, W.;
Weller, M.

Publication type:

Article

Suppression of P2-T-Cell Line Mediated Experimental Autoimmune Neuritis by Interleukin-2 Receptor Blockade.

Published in:

Annals of the New York Academy of Sciences, 1988, v. 540, n. 1, p. 563, doi. 10.1111/j.1749-6632.1988.tb27173.x

By:

HARTUNG, H. P.;
SCHÄFER, B.;
DIAMANTSTEIN, T.;
FIERZ, W.;
HEININGER, K.;
TOYKA, K. V.

Publication type:

Article

Immune Mechanisms in Inflammatory Polyneuropathya.

Published in:

Annals of the New York Academy of Sciences, 1988, v. 540, n. 1, p. 122, doi. 10.1111/j.1749-6632.1988.tb27058.x

By:

HARTUNG, H. P.;
HEININGER, K.;
SCHÄFER, B.;
FIERZ, W.;
TOYKA, K. V.

Publication type:

Article

Therapeutic Plasma Exchange in Myasthenia Gravis: Semiselective Adsorption of Anti-AChR Autoantibodies with Tryptophane Linked Polyvinylalcohol Gels.

Published in:

Annals of the New York Academy of Sciences, 1987, v. 505, n. 1, p. 898, doi. 10.1111/j.1749-6632.1987.tb51406.x

By:

HEININGER, K.;
HARTUNG, H.-P.;
TOYKA, K. V.;
GACZKOWSKI, A.;
BORBERG, H.

Publication type:

Article

Zerebrale Sekundärprävention — Clopidogrel allein oder in Kombination mit ASS.

Published in:

Der Internist, 2005, v. 46, n. 11, p. 1278, doi. 10.1007/s00108-005-1507-5

By:

Nitschmann, S.;
Hartung, H.-P.;
Siebler, M.

Publication type:

Article

Patient‐reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study.

Published in:

European Journal of Neurology, 2020, v. 27, n. 1, p. 196, doi. 10.1111/ene.14056

By:

Hartung, H.‐P.;
Mallick, R.;
Bril, V.;
Lewis, R. A.;
Sobue, G.;
Lawo, J.‐P.;
Mielke, O.;
Durn, B. L.;
Cornblath, D. R.;
Merkies, I. S. J.;
van Schaik, I. N.

Publication type:

Article

Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis.

Published in:

Brain: A Journal of Neurology, 2003, v. 126, n. 8, p. 1873, doi. 10.1093/brain/awg171

By:

R. Paul;
U. Koedel;
F. Winkler;
B.C. Kieseier;
A. Fontana;
M. Kopf;
Hartung H.-P.;
Pfister H.-W.

Publication type:

Article

Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder?

Published in:

Brain: A Journal of Neurology, 2002, v. 125, n. 6, p. 1320, doi. 10.1093/brain/awf127

By:

De Jonghe, P.;
Auer‐Grumbach, M.;
Irobi, J.;
Wagner, K.;
Plecko, B.;
Kennerson, M.;
Zhu, D.;
De Vriendt, E.;
Van Gerwen, V.;
Nicholson, G.;
Hartung, H.‐P.;
Timmerman, V.

Publication type:

Article

Suppression of experimental autoimmune neuritis by leflunomide.

Published in:

2001

By:

Korn, T;
Toyka, K;
Hartung, H P;
Jung, S

Publication type:

journal article

Phenotypic and genotypic heterogeneity in hereditary motor neuronopathy type V: a clinical, electrophysiological and genetic study.

Published in:

2000

By:

Auer-Grumbach, M;
Löscher, W N;
Wagner, K;
Petek, E;
Körner, E;
Offenbacher, H;
Hartung, H P

Publication type:

journal article

T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy.

Published in:

2000

By:

Schmidt, J;
Gold, R;
Schönrock, L;
Zettl, U K;
Hartung, H P;
Toyka, K V

Publication type:

journal article

The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat.

Published in:

Brain: A Journal of Neurology, 1998, v. 121, n. 7, p. 1257, doi. 10.1093/brain/121.7.1257

By:

Enders, U;
Lobb, R;
Pepinsky, RB;
Hartung, H-P;
Toyka, KV;
Gold, R

Publication type:

Article

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

Published in:

Brain: A Journal of Neurology, 1998, v. 121, n. 1, p. 159, doi. 10.1093/brain/121.1.159

By:

Kieseier, BC;
Kiefer, R;
Clements, JM;
Miller, K;
Wells, GMA;
Schweitzer, T;
Gearing, AJH;
Hartung, H-P

Publication type:

Article

Power spectrum analysis of heart rate variability in Guillain-BarrÃ© syndrome. A longitudinal study.

Published in:

Brain: A Journal of Neurology, 1997, v. 120, n. 10, p. 1885, doi. 10.1093/brain/120.10.1885

By:

Flachenecker, P;
Hartung, H P;
Reiners, K

Publication type:

Article

Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death.

Published in:

Brain: A Journal of Neurology, 1996, v. 119, n. 2, p. 651, doi. 10.1093/brain/119.2.651

By:

Gold, R.;
Schmied, M.;
Tontsch, U.;
Hartung, H. P.;
Wekerle, H.;
Toyka, K. V.;
Lassmann, H.

Publication type:

Article

P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.

Published in:

2001

By:

Yan, Wei Xing;
Archelos, Juan J.;
Hartung, Hans-Peter;
Pollard, John D.;
Yan, W X;
Archelos, J J;
Hartung, H P;
Pollard, J D

Publication type:

journal article

Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis.

Published in:

2001

By:

Krametter, D.;
Niederwieser, G.;
Berghold, A.;
Birnbaum, G.;
Strasser-Fuchs, S.;
Hartung, H.-P.;
Archelos, J.J.

Publication type:

commentary

Electrophysiological classification of guillain-barré syndrome: Clinical associations and outcome.

Published in:

Annals of Neurology, 1998, v. 44, n. 5, p. 780, doi. 10.1002/ana.410440512

By:

Hadden, R. D. M.;
Cornblath, D. R.;
Hughes, R. A. C.;
Zielasek, J.;
Hartung, H.-P.;
Toyka, K. V.;
Swan, A. V.

Publication type:

Article

Expression of integrins in experimental autoimmune neuritis and guillain-barré syndrome.

Published in:

Annals of Neurology, 1998, v. 44, n. 4, p. 611, doi. 10.1002/ana.410440406

By:

Previtali, S. C.;
Archelos, J. J.;
Hartung, H.-P.

Publication type:

Article

Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the guillain-barré syndrome.

Published in:

Annals of Neurology, 1998, v. 43, n. 4, p. 427, doi. 10.1002/ana.410430404

By:

Kieseier, B. C.;
Clements, J. M.;
Pischel, H. B.;
Wells, G. M. A.;
Miller, K.;
Gearing, A. J. H.;
Hartung, H.-P.

Publication type:

Article

Quantitative assessment of cardiovascular autonomic function in Guillain-Barré syndrome.

Published in:

Annals of Neurology, 1997, v. 42, n. 2, p. 171, doi. 10.1002/ana.410420207

By:

Flachenecker, P.;
Wermuth, P.;
Hartung, H.-P.;
Reiners, K.

Publication type:

Article

Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody.

Published in:

Annals of Neurology, 1995, v. 37, n. 4, p. 467, doi. 10.1002/ana.410370409

By:

Pollard, J. D.;
Westland, K. W.;
Harvey, G. K.;
Jung, S.;
Bonner, J.;
Spies, J. M.;
Toyka, K. V.;
Hartung, H.-P.

Publication type:

Article

Myasthenia gravis: Discontinuation of long-term azathioprine.

Published in:

Annals of Neurology, 1988, v. 24, n. 6, p. 798, doi. 10.1002/ana.410240619

By:

Michels, M.;
Hohlfeld, R.;
Hartung, H.-P.;
Heininger, K.;
Besinger, U. A.;
Toyka, K. V.

Publication type:

Article

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.

Published in:

2016

By:

Ingwersen, J.;
Wingerath, B.;
Graf, J.;
Lepka, K.;
Hofrichter, M.;
Schröter, F.;
Wedekind, F.;
Bauer, A.;
Schrader, J.;
Hartung, H.-P.;
Prozorovski, T.;
Aktas, O.

Publication type:

journal article

Detection of Oxidative Burst and Apoptofic Cell Death in Cerebrospinal Fluid (CSF) and Biood.

Published in:

Journal of Laboratory Medicine / Laboratoriums Medizin, 1996, v. 20, n. 3, p. 176

By:

Zettl, U. K.;
Mix, E.;
Gold, R.;
Rothe, G.;
Hartung, H.-P.

Publication type:

Article

Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis?

Published in:

Clinical & Experimental Immunology, 2018, v. 193, n. 3, p. 341, doi. 10.1111/cei.13148

By:

Kraayvanger, L.;
Berlit, P.;
Albrecht, P.;
Hartung, H.‐P.;
Kraemer, M.

Publication type:

Article

Bacteria and their cell wall components uniformly co-activate interleukin-17-producing thymocytes.

Published in:

Clinical & Experimental Immunology, 2014, v. 178, n. 3, p. 504, doi. 10.1111/cei.12414

By:

Weber, A.;
Zimmermann, C.;
Kieseier, B. C.;
Hartung, H.‐P.;
Hofstetter, H. H.

Publication type:

Article

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.

Published in:

Clinical & Experimental Immunology, 2014, v. 175, n. 3, p. 397, doi. 10.1111/cei.12206

By:

Rommer, P. S.;
Zettl, U. K.;
Kieseier, B.;
Hartung, H.‐P.;
Menge, T.;
Frohman, E.;
Greenberg, B. M.;
Hemmer, B.;
Stüve, O.

Publication type:

Article

T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes.

Published in:

Clinical & Experimental Immunology, 2013, v. 172, n. 2, p. 245, doi. 10.1111/cei.12037

By:

Zimmermann, C.;
Weber, A.;
Mausberg, A. K.;
Kieseier, B. C.;
Hartung, H. P.;
Hofstetter, H. H.

Publication type:

Article

Clinical applications of intravenous immunoglobulins (IVIg) – beyond immunodeficiencies and neurology.

Published in:

Clinical & Experimental Immunology, 2009, v. 158, p. 23, doi. 10.1111/j.1365-2249.2009.04024.x

By:

Hartung, H.-P.;
Mouthon, L.;
Ahmed, R.;
Jordan, S.;
Laupland, K. B.;
Jolles, S.

Publication type:

Article

Investigator in training.

Published in:

Journal of NeuroVirology, 2002, v. 8, p. 20, doi. 10.1080/13550280290049868

By:

Wigdahl, B.;
Hartung, H.-P.

Publication type:

Article

Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.

Published in:

Multiple Sclerosis Journal, 2014, v. 20, n. 7, p. 882, doi. 10.1177/1352458513510981

By:

Ringelstein, M;
Metz, I;
Ruprecht, K;
Koch, A;
Rappold, J;
Ingwersen, J;
Mathys, C;
Jarius, S;
Brück, W;
Hartung, H-P;
Paul, F;
Aktas, O

Publication type:

Article

Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.

Published in:

2013

By:

Ringelstein, M;
Harmel, J;
Distelmaier, F;
Ingwersen, J;
Menge, T;
Hellwig, K;
Kieseier, B;
Mayatepek, E;
Hartung, H-P;
Kuempfel, T;
Aktas, O

Publication type:

Case Study

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.

Published in:

Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 966, doi. 10.1177/1352458511432327

By:

Freedman, MS;
Metzig, C;
Kappos, L;
Polman, CH;
Edan, G;
Hartung, H-P;
Miller, DH;
Montalban, X;
Yarden, J;
Spector, L;
Fire, E;
Dotan, N;
Schwenke, S;
Lanius, V;
Sandbrink, R;
Pohl, C

Publication type:

Article

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Published in:

Multiple Sclerosis Journal, 2012, v. 18, n. 6, p. 891, doi. 10.1177/1352458511431076

By:

Langdon, DW;
Amato, MP;
Boringa, J;
Brochet, B;
Foley, F;
Fredrikson, S;
Hämäläinen, P;
Hartung, H-P;
Krupp, L;
Penner, IK;
Reder, AT;
Benedict, RHB

Publication type:

Article